company background image
383 logo

Tian An Medicare SEHK:383 Stock Report

Last Price

HK$0.75

Market Cap

HK$814.5m

7D

8.7%

1Y

-6.3%

Updated

24 Nov, 2024

Data

Company Financials

Tian An Medicare Limited

SEHK:383 Stock Report

Market Cap: HK$814.5m

383 Stock Overview

An investment holding company, primarily operates hospitals in the People’s Republic of China and Hong Kong. More details

383 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for 383 from our risk checks.

Tian An Medicare Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Tian An Medicare
Historical stock prices
Current Share PriceHK$0.75
52 Week HighHK$1.00
52 Week LowHK$0.58
Beta0.67
11 Month Change-1.32%
3 Month Change-11.76%
1 Year Change-6.25%
33 Year Change-53.13%
5 Year Change-75.00%
Change since IPO803.83%

Recent News & Updates

Recent updates

China Medical & HealthCare Group's (HKG:383) Returns On Capital Not Reflecting Well On The Business

Feb 02
China Medical & HealthCare Group's (HKG:383) Returns On Capital Not Reflecting Well On The Business

Returns On Capital Signal Difficult Times Ahead For China Medical & HealthCare Group (HKG:383)

Oct 26
Returns On Capital Signal Difficult Times Ahead For China Medical & HealthCare Group (HKG:383)

Is China Medical & HealthCare Group (HKG:383) Using Debt In A Risky Way?

Sep 30
Is China Medical & HealthCare Group (HKG:383) Using Debt In A Risky Way?

China Medical & HealthCare Group (HKG:383) Might Have The Makings Of A Multi-Bagger

Dec 10
China Medical & HealthCare Group (HKG:383) Might Have The Makings Of A Multi-Bagger

We Think China Medical & HealthCare Group (HKG:383) Has A Fair Chunk Of Debt

Apr 08
We Think China Medical & HealthCare Group (HKG:383) Has A Fair Chunk Of Debt

Do Institutions Own China Medical & HealthCare Group Limited (HKG:383) Shares?

Feb 14
Do Institutions Own China Medical & HealthCare Group Limited (HKG:383) Shares?

Is China Medical & HealthCare Group (HKG:383) A Risky Investment?

Dec 22
Is China Medical & HealthCare Group (HKG:383) A Risky Investment?

Shareholder Returns

383HK HealthcareHK Market
7D8.7%-1.5%-0.6%
1Y-6.3%-27.6%9.6%

Return vs Industry: 383 exceeded the Hong Kong Healthcare industry which returned -27.6% over the past year.

Return vs Market: 383 underperformed the Hong Kong Market which returned 9.6% over the past year.

Price Volatility

Is 383's price volatile compared to industry and market?
383 volatility
383 Average Weekly Movement7.2%
Healthcare Industry Average Movement8.0%
Market Average Movement8.9%
10% most volatile stocks in HK Market19.2%
10% least volatile stocks in HK Market4.3%

Stable Share Price: 383 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Volatility Over Time: 383's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19892,587n/awww.tiananmedicare.com.hk

Tian An Medicare Limited, an investment holding company, primarily operates hospitals in the People’s Republic of China and Hong Kong. It operates through six segments: Healthcare, Eldercare, Property Development, Property Investment, Financial Services, and Securities Trading and Investments. The company also involved in property development of independent living units and project management of health campus with a focus on eldercare and retirement community including elderly nursing home, service apartments, independent living units and commercial area comprising shopping mall, retail shops, and club hall facilities.

Tian An Medicare Limited Fundamentals Summary

How do Tian An Medicare's earnings and revenue compare to its market cap?
383 fundamental statistics
Market capHK$814.50m
Earnings (TTM)HK$31.64m
Revenue (TTM)HK$1.63b

25.7x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
383 income statement (TTM)
RevenueHK$1.63b
Cost of RevenueHK$1.32b
Gross ProfitHK$305.20m
Other ExpensesHK$273.56m
EarningsHK$31.64m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.029
Gross Margin18.73%
Net Profit Margin1.94%
Debt/Equity Ratio42.6%

How did 383 perform over the long term?

See historical performance and comparison

Dividends

1.3%

Current Dividend Yield

34%

Payout Ratio